Novo Nordisk (NVO) is upgraded to 'Hold' as its market cap returns to pre-GLP-1 mania levels, limiting further downside. NVO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results